Al Nahdi Medical Company SCJSC banner

Al Nahdi Medical Company SCJSC
SAU:4164

Watchlist Manager
Al Nahdi Medical Company SCJSC Logo
Al Nahdi Medical Company SCJSC
SAU:4164
Watchlist
Price: 129.2 SAR -0.92% Market Closed
Market Cap: ﷼16.8B

Wall St Price Targets

Price Targets Summary
Al Nahdi Medical Company SCJSC

Wall Street analysts forecast Al Nahdi Medical Company SCJSC stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Al Nahdi Medical Company SCJSC is 128.03 SAR with a low forecast of 106.2 SAR and a high forecast of 149.1 SAR.

Lowest Forecast
Price Target
106.2 SAR
18% Downside
Average Forecast
Price Target
128.03 SAR
1% Downside
Highest Forecast
Price Target
149.1 SAR
15% Upside
Al Nahdi Medical Company SCJSC Competitors:
Price Targets
ARTO
Bank Jago Tbk PT
113% Upside

Revenue
Forecast

5% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
5% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 7 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is 8%.

Gross Profit
Forecast

9% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
9% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 7 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 3 years is 8%.

Operating Income
Forecast

5% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
5% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 7 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 3 years is 8%.

Pre-Tax Income
Forecast

4% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
4% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 7 years, the compound annual growth rate for Pre-Tax Income has been 4%. The projected CAGR for the next 3 years is 9%.

Net Income
Forecast

4% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
4% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 7 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 3 years is 9%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is Al Nahdi Medical Company SCJSC's stock price target?
Price Target
128.03 SAR

According to Wall Street analysts, the average 1-year price target for Al Nahdi Medical Company SCJSC is 128.03 SAR with a low forecast of 106.2 SAR and a high forecast of 149.1 SAR.

What is the Revenue forecast for Al Nahdi Medical Company SCJSC?
Projected CAGR
8%

Over the last 7 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is 8%.

What is the Gross Profit forecast for Al Nahdi Medical Company SCJSC?
Projected CAGR
8%

Over the last 7 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 3 years is 8%.

What is the Operating Income forecast for Al Nahdi Medical Company SCJSC?
Projected CAGR
8%

Over the last 7 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 3 years is 8%.

What is the Pre-Tax Income forecast for Al Nahdi Medical Company SCJSC?
Projected CAGR
9%

Over the last 7 years, the compound annual growth rate for Pre-Tax Income has been 4%. The projected CAGR for the next 3 years is 9%.

What is the Net Income forecast for Al Nahdi Medical Company SCJSC?
Projected CAGR
9%

Over the last 7 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 3 years is 9%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett